期刊文献+

Lactobacilli,bifi dobacteria and E.coli nissle induce pro-and anti-inflammatory cytokines in peripheral blood mononuclear cells 被引量:3

Lactobacilli,bifi dobacteria and E.coli nissle induce pro-and anti-inflammatory cytokines in peripheral blood mononuclear cells
下载PDF
导出
摘要 AIM: To investigate whether the stimulation of peripher- al blood mononuclear cells (PBMNC) with the cell debris and cell extraction of different probiotic strains is similar or species specifi c. METHODS: Three strains of bifi dobacteria, 4 strains of lactobacilli, and E. coli nissle were sonicated and centri- fuged in order to divide them into cell extract and cell debris. PBMNC were separated by density gradient and incubated for 36 h with either the cell debris or the cell extract of single strains of probiotic bacteria in doses from 102 to 108 CFU/mL. Cell supernatants were taken and interleukin (IL)-10, IL-1β, and tumor necosis factor (TNF)-α were determined by ELISA. RESULTS: Depending on the species super-family, the strains had different stimulation patterns. Except for both L. casei strains, the cell extract of bifidobacteriaand lactobacilli had less stimulating capacity than cell debris, whereas the cell extract of E. coli nissle had simi- lar stimulating properties to that of the cell debris of the strain and significantly more stimulating capacity than that of bifi dobacteria and lactobacilli. The cell debris of bifi dobacteria stimulated more cytokine release than the cell debris of lactobacilli. The cell debris of lactobacilli did not have a stimulating capacity when lower concentra- tions were used. Neither cell extraction nor cell debris had an inhibitory effect on the production of the tested cytokines by stimulated PBMNC. CONCLUSION: The incubation of probiotic strains, which have been used in clinical trials for inflammatory diseases, with immunocompetent cells leads to different species specifi c reactions. High IL-10 response to cell de- bris of bifi dobacteria and E. coli nissle can be found. This corresponds to positive effects of bifi dobacteria and E. coli nissle in clinical trials for inflammatory bowel disease compared to negative outcomes obtained with lactoba- cilli. AIM: To investigate whether the stimulation of peripheral blood mononuclear cells (PBMNC) with the cell debris and cell extraction of different probiotic strains is similar or species specific. METHODS: Three strains of bifidobacteria, 4 strains of lactobacilli, and E. coli nissle were sonicated and centrifuged in order to divide them into cell extract and cell debris. PBMNC were separated by density gradient and incubated for 36 h with either the cell debris or the cell extract of single strains of probiotic bacteria in doses from 10^2 to 10^8 CFU/mL. Cell supernatants were taken and interleukin (IL)-10, IL-1β, and tumor necosis factor (TNF)-α were determined by ELISA. RESULTS: Depending on the species super-family, the strains had different stimulation patterns. Except for both L. casei strains, the cell extract of bitTdobacteria and/actobacilli had less stimulating capacity than cell debris, whereas the cell extract of E. coli nissle had similar stimulating properties to that of the cell debris of the strain and significantly more stimulating capacity than that of bifidobacteria and lactobacilli. The cell debris of bifidobacteria stimulated more cytokine release than the cell debris of lactobacilli. The cell debris of lactobacilli did not have a stimulating capacity when lower concentrations were used. Neither cell extraction nor cell debris had an inhibitory effect on the production of the tested cytokines by stimulated PBMNC. CONCLUSION: The incubation of probiotic strains, which have been used in clinical trials for inflammatory diseases, with immunocompetent cells leads to different species specific reactions. High IL-10 response to cell debris of bifidobacteria and E. coli nissle can be found. This corresponds to positive effects of bihdobacteria and E. coli nissle in clinical trials for inflammatory bowel disease compared to negative outcomes obtained with lactobacilli.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第37期5978-5986,共9页 世界胃肠病学杂志(英文版)
基金 Supported by a grant from "Trainig and Mobility of Researchers" program, RX-CT98-0240
关键词 细胞活素类 外周血 单核细胞 前生命期 Lactobacilli Bifidobacteria Probiotics Interleukin-l0 Tumor necrosis factor-α Interleukin-1β Peripheral blood mononuclear cells
  • 相关文献

参考文献42

  • 1[1]MacDonald TT,Pettersson S.Bacterial regulation of intestinal immune responses.Inflamm Bowel Dis 2000; 6:116-122
  • 2[2]Sartor RB.Review article:Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis.Aliment Pharmacol Ther 1997; 11 Suppl 3:17-22; discussion 22-23
  • 3[3]Campieri M,Gionchetti P.Bacteria as the cause of ulcerative colitis.Gut 2001; 48:132-135
  • 4[4]Janowitz HD,Croen EC,Sachar DB.The role of the fecal stream in Crohn's disease:an historical and analytic review.Inflamm Bowel Dis 1998; 4:29-39
  • 5[5]Rembacken BJ,Snelling AM,Hawkey PM,Chalmers DM,Axon AT.Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:a randomised trial.Lancet 1999; 354:635-639
  • 6[6]Kruis W,Schutz E,Fric P,Fixa B,Judmaier G,Stolte M.Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.Aliment Pharmacol Ther 1997; 11:853-858
  • 7[7]Prantera C,Scribano ML,Falasco G,Andreoli A,Luzi C.Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease:a randomised controlled trial with Lactobacillus GG.Gut 2002; 51:405-409
  • 8[8]Schultz M,Timmer A,Herfarth HH,Sartor RB,Vanderhoof JA,Rath HC.Lactobacillus GG in inducing and maintaining remission of Crohn's disease.BMC Gastroenterol 2004; 4:5
  • 9[9]Gionchetti P,Rizzello F,Venturi A,Brigidi P,Matteuzzi D,Bazzocchi G,Poggioli G,Miglioli M,Campieri M.Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis:a double-blind,placebo-controlled trial.Gastroenterology 2000; 119:305-309
  • 10[10]Mimura T,Rizzello F,Helwig U,Poggioli G,Schreiber S,Talbot IC,Nicholls RJ,Gionchetti P,Campieri M,Kamm MA.Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.Gut 2004; 53:108-114

同被引文献50

  • 1唐志如,邓欢,孙卫忠,张小龙,张翥.口服益生菌Escherichia coli Nissle 1917调控断奶仔猪空肠黏膜屏障功能的机理研究[J].畜牧兽医学报,2014,45(1):78-86. 被引量:5
  • 2Benoit Foligne,Sophie Nutten,Corinne Grangette,Véronique Dennin,Denise Goudercourt,Sabine Poiret,Joelle Dewulf,Dominique Brassart,Annick Mercenier,Bruno Pot.Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria[J].World Journal of Gastroenterology,2007,13(2):236-243. 被引量:22
  • 3Jennifer L. Jones,Amy E. Foxx-Orenstein.The Role of Probiotics in Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.2007(3)
  • 4Lammers KM,Brigidi P,Vitali B,Gionchetti P,Rizzello F,Caramelli E,Matteuzzi D,Campieri M.Immunomodulatory effects of probiotic bacteria DNA:IL-1and IL-10response in human peripheral blood mononuclear cells[].FEMS Immunology and Medical Microbiology.2003
  • 5FAO/WHO.Guidelines for the evaluation of probiotics in food[].Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food.2002
  • 6Saxelin M,Tynkkynen S,Mattila-Sandholm T,de Vos WM.Probiotic and other functional microbes:from markets to mechanisms[].Current Opinion in Biotechnology.2005
  • 7Vaarala O.Immunological effects of probiotics with special reference to lactobacilli[].Clinical and Experimental Allergy.2003
  • 8Ezendam J,van Loveren H.Probiotics:immunomodulation and evaluation of safety and efficacy[].Nutrition Reviews.2006
  • 9Hehlgans T,Pfeffer K.The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily:players,rules and the games[].Immunology.2005
  • 10Taylor A,Verhagen J,Blaser K,Akdis M,Akdis CA.Mechanisms of immune suppression by interleukin-10and transforming growth factor-beta:the role of T regulatory cells[].Immunology.2006

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部